GlassScriptPhysician profile
James D Loebell
NPI 1700839222
$1,592.37
in general payments reported to CMS, 2019-2025
21 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.25 · 2020: $41.80 · 2021: $359 · 2022: $61.61 · 2023: $269 · 2024: $646 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $231.22 | 2021-2024 | Nuzyra |
| Kerecis Limited | $180.53 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $144.31 | 2023-2025 | Viaflow, Fuseforce, Citrefix |
| Smith+Nephew, INC. | $143.58 | 2021-2025 | Collagenase Santyl, Grafix Pl |
| Vaporox, INC. | $142.92 | 2024 | Vht-200 Wound Treatment System |
| Linvatec Corporation | $134.23 | 2023 | Quantum, Colink 2, In2bones USA |
| Organogenesis INC. | $100.92 | 2020-2022 | |
| Mvp Orthopedics INC | $86.72 | 2021-2023 | |
| Nevro Corp. | $81.57 | 2022-2024 | Senza |
| Averitas Pharma INC. | $54.55 | 2024-2025 | Qutenza |
| Melinta Therapeutics, LLC | $50.62 | 2019 | |
| Horizon Therapeutics Plc | $38.98 | 2021 | |
| Treace Medical Concepts, INC. | $36.52 | 2024 | |
| Merck Sharp & Dohme LLC | $33.38 | 2019 | |
| Ets Wound Care LLC | $29.94 | 2024 | Mirragen Advanced Wound Matrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.73 | 2023 | |
| Ibsa Pharma INC. | $20.28 | 2024 | Tirosint, Licart |
| Inari Medical, INC. | $17.91 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $16.09 | 2020 | |
| Orthofix Medical, INC. | $15.12 | 2024 | Physio-Stim |
| Kci USA, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Loebell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.